GenoLogics Partners with GeneBio
News May 25, 2006
GenoLogics Life Sciences Software Inc. and Geneva Bioinformatics SA have announced a collaboration that will provide life science researchers a broader solution for managing and analyzing proteomics data by integrating GeneBio’s Phenyx, a proteomics MS data analysis platform with GenoLogics’ Proteus™, a lab and data management software solution.
Under the terms of the agreement, GeneBio’s Phenyx, a software platform for the identification and characterization of proteins and peptides from mass spectrometry data will be capable of data integration with GenoLogics’ Proteus, solution for proteomics purposed lab and scientific data management and analysis.
"We are extremely pleased to be partnering with GenoLogics to provide life science researchers with this valuable integration," commented Nasri Nahas, CEO of GeneBio.
"Phenyx has had a remarkable response from the life science sector since its inception."
"The next step in the evolution of Phenyx is to increase its availability to potential customers through integration with broader solutions; in this manner, Phenyx can be utilized both as a standalone product and as an integral part of a more comprehensive environment."
"A lab information and data management system is a logical environment for such an integration, and Proteus is an excellent solution with which to have Phenyx associated."
"Our collaboration will benefit both new and existing customers alike by giving them the combined expertise of our two companies."
"Our goal is to offer customers the best available solution for their specific lab information and data management needs," commented Michael Ball, CEO of GenoLogics.
"This particular integration will allow us to provide a broader solution to many of our customers, allowing researchers better data management capabilities augmented by greater insight into their data, thereby accelerating the discovery timeline."
"This partnership unites leaders in lab information and data management, and protein identification and characterization, and the Phenyx integration will be welcomed by many of our existing and potential proteomics customers."
Representatives of both GeneBio (booth #79) and GenoLogics (booth #95) will be at the ASMS Conference in Seattle, WA, to answer questions concerning this partnership and their respective products.
Two proteins that activate the fastest molecule in our nerve cells have been identified by researchers at University of Warwick. This mechanism is responsible for transport through our nervous system. This finding could lead to a new therapeutic treatments for people with hereditary spastic paraplegia and other neurological disorders.READ MORE